Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Expression of galectins in cancer: a critical review.

Literature DB >> 14758077

Expression of galectins in cancer: a critical review.

Frédéric van den Brûle¹, Stèphane Califice, Vincent Castronovo.

Abstract

A large body of literature has examined and described galectin expression in cancer. Discrepancies have been observed in the reported data, which hampered clear understanding of the expression profiles. This relates to the use of different types of methods that evaluate either global or specific gene expression in heterogeneous cancer tissue samples, type of antibodies used in immunohistochemistry and procedures of comparison of gene expression. In this manuscript, we review the main data concerning expression of galectins in human cancer. Only galectin-1 and galectin-3, the most abundant and examined galectins, will be examined here.

Entities: Disease Gene Species

Mesh：

Substances：
Galectin 1
Galectin 3

Year: 2002 PMID： 14758077 DOI： 10.1023/B:GLYC.0000014083.48508.6a

Source DB: PubMed Journal: Glycoconj J ISSN： 0282-0080 Impact factor: 2.916

79 in total

1. Galectin-3 expression is induced in cirrhotic liver and hepatocellular carcinoma.

Authors: D K Hsu; C A Dowling; K C Jeng; J T Chen; R Y Yang; F T Liu
Journal: Int J Cancer Date: 1999-05-17 Impact factor: 7.396

2. Methodological considerations regarding the use of galectin-3 expression analysis in preoperative evaluation of thyroid nodules.

Authors: Armando Bartolazzi; Mauro Papotti; Fabio Orlandi
Journal: J Clin Endocrinol Metab Date: 2003-02 Impact factor: 5.958

3. Decreased expression of galectin-3 is associated with progression of human breast cancer.

Authors: V Castronovo; F A Van Den Brûle; P Jackers; N Clausse; F T Liu; C Gillet; M E Sobel
Journal: J Pathol Date: 1996-05 Impact factor: 7.996

4. The levels of expression of galectin-1, galectin-3, and the Thomsen-Friedenreich antigen and their binding sites decrease as clinical aggressiveness increases in head and neck cancers.

Authors: G Choufani; N Nagy; S Saussez; H Marchant; P Bisschop; M Burchert; A Danguy; S Louryan; I Salmon; H J Gabius; R Kiss; S Hassid
Journal: Cancer Date: 1999-12-01 Impact factor: 6.860

5. Characterization of gene expression profiles in intraductal papillary-mucinous tumors of the pancreas.

Authors: Benoit Terris; Ekaterina Blaveri; Tatjana Crnogorac-Jurcevic; Melanie Jones; Edoardo Missiaglia; Philippe Ruszniewski; Alain Sauvanet; Nicholas R Lemoine
Journal: Am J Pathol Date: 2002-05 Impact factor: 4.307

6. Identification of carbohydrate binding protein 35 in heterogeneous nuclear ribonucleoprotein complex.

Authors: J G Laing; J L Wang
Journal: Biochemistry Date: 1988-07-12 Impact factor: 3.162

7. Galectin-3 and carcinoembryonic antigen expression in medullary thyroid carcinoma: possible relation to tumour progression.

Authors: D Cvejic; S Savin; S Golubovic; I Paunovic; S Tatic; M Havelka
Journal: Histopathology Date: 2000-12 Impact factor: 5.087

8. Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications.

Authors: X C Xu; A K el-Naggar; R Lotan
Journal: Am J Pathol Date: 1995-09 Impact factor: 4.307

9. Localization of endogenous lectins in normal human breast, benign breast lesions and mammary carcinomas.

Authors: H J Gabius; R Brehler; A Schauer; F Cramer
Journal: Virchows Arch B Cell Pathol Incl Mol Pathol Date: 1986

10. Identification of galectin-3 as a factor in pre-mRNA splicing.

Authors: S F Dagher; J L Wang; R J Patterson
Journal: Proc Natl Acad Sci U S A Date: 1995-02-14 Impact factor: 11.205

57 in total

Review 1. Introduction to galectins.

Authors: Hakon Leffler; Susanne Carlsson; Maria Hedlund; Yuning Qian; Francoise Poirier
Journal: Glycoconj J Date: 2002 Impact factor: 2.916

Review 2. Pathobiological implications of mucin glycans in cancer: Sweet poison and novel targets.

Authors: Seema Chugh; Vinayaga S Gnanapragassam; Maneesh Jain; Satyanarayana Rachagani; Moorthy P Ponnusamy; Surinder K Batra
Journal: Biochim Biophys Acta Date: 2015-08-28

3. CD24 and galectin-1 expressions in gastric adenocarcinoma and clinicopathologic significance.

Authors: Sibel Bektas; Burak Bahadir; Bulent Hamdi Ucan; Sukru Oguz Ozdamar
Journal: Pathol Oncol Res Date: 2010-02-23 Impact factor: 3.201

4. Myenteric denervation downregulates galectin-1 and -3 expression in gastric carcinogenesis.

Authors: Cássia F Estofolete; Sérgio Zucoloto; Sonia M Oliani; Ana Cláudia Polli-Lopes; Cristiane D Gil
Journal: Dig Dis Sci Date: 2010-12-29 Impact factor: 3.199

5. The galectin profile of the endothelium: altered expression and localization in activated and tumor endothelial cells.

Authors: Victor L Thijssen; Sarah Hulsmans; Arjan W Griffioen
Journal: Am J Pathol Date: 2008-01-17 Impact factor: 4.307

6. Effect of extended conjugation with a phenylethynyl group on the fluorescent properties of water-soluble arylboronic acids.

Authors: Shi-Long Zheng; Na Lin; Suazette Reid; Binghe Wang
Journal: Tetrahedron Date: 2007-06-18 Impact factor: 2.457

10. Expression profiling of Galectin-3-depleted melanoma cells reveals its major role in melanoma cell plasticity and vasculogenic mimicry.

Authors: Alexandra A Mourad-Zeidan; Vladislava O Melnikova; Hua Wang; Avraham Raz; Menashe Bar-Eli
Journal: Am J Pathol Date: 2008-11-06 Impact factor: 4.307